CEL-SCI CEO Geert Kersten Was a Featured Guest on Fox Business’ Making Money with Charles Payne
February 18 2016 - 7:45AM
Business Wire
CEL-SCI Corporation (NYSE MKT:CVM) announced today that
its Chief Executive Officer Geert Kersten was a guest on Fox
Business’ Making Money with Charles Payne. The segment, which
focused on finding a cure to cancer aired on Wednesday, February 17
between 6:00 and 7:00 p.m. ET. To view the segment, please visit:
http://video.foxbusiness.com/v/4761247378001/are-scientists-on-the-cusp-of-finding-a-cure-for-cancer/?#sp=show-clips
About CEL-SCI Corporation
CEL-SCI is a Phase 3 immunotherapy company with platform
technologies that can potentially treat a variety of cancers and
viral diseases. We believe that one must activate the immune system
BEFORE radiation and chemotherapy, and even before surgery, to
achieve the best results in the greatest number of patients.
CEL-SCI is conducting a Phase 3 trial in 24 countries of Multikine
(Leukocyte Interleukin Injection) for the treatment of head and
neck cancer, which accounts for about 6% of cancers globally and a
$6 billion market. Almost 700 patients are already enrolled in this
study. CEL-SCI is also testing Multikine with the U.S. Navy in HIV
infected patients with HPV related diseases. CEL-SCI has
development partnerships with Teva Pharmaceuticals, Orient
EuroPharma of Taiwan, Ergomed and the NIH. The Company operates its
own 75,000 sq. ft. manufacturing facility and produces Multikine
for its clinical trials. When fully built out, this facility will
have the capacity to supply about $3 billion worth of Multikine
annually. CEL-SCI is also developing its pre-clinical L.E.A.P.S.
(Ligand Epitope Antigen Presentation System) technology as a
potential vaccine for the treatment of rheumatoid arthritis.
The Company has operations in Vienna, Virginia, and in/near
Baltimore, Maryland.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160218005529/en/
For CEL-SCI Corporation:Gavin de Windt,
703-506-9460www.cel-sci.com
Cel Sci (AMEX:CVM)
Historical Stock Chart
From Apr 2024 to May 2024
Cel Sci (AMEX:CVM)
Historical Stock Chart
From May 2023 to May 2024